Vimarsana
Biggest News Aggregation in the World

Alternative Lengthening News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alternative Lengthening. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alternative Lengthening Today - Breaking & Trending Today

Tessellate BIO Emerges from Stealth - Replimune Group (NASDAQ:REPL), NewAmsterdam Pharma (NASDAQ:NAMS) - Vimarsana News

Tessellate BIO Emerges from Stealth - Replimune Group (NASDAQ:REPL), NewAmsterdam Pharma (NASDAQ:NAMS)

The company aims to become a global leader in precision oncology by redefining Synthetic Lethality to treat large, currently unserved patient populationsLead program targets Alternative Lengthening of Telomeres (ALT)

Tessellate BIO Raises Initial €8M in Seed Funding - Vimarsana News

Tessellate BIO Raises Initial €8M in Seed Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Sydney researchers awarded $22 million for medical research - Vimarsana News

Sydney researchers awarded $22 million for medical research

Genomics Health Futures Mission Professor Anne Cust, Deputy Director of the Daffodil Centre, was awarded $3 million to deliver improved practice and policy-relevant genomic risk prediction and increase the effectiveness of cancer screening and early detection services for the four most common cancers in Australia –breast, prostate, melanoma and colorectal cancers. Working directly with consumers, health professionals and policy stakeholders, the team aim to reduce the cancer burden and help Australians live longer and healthier lives. Childhood Cancer Research Associate Professor Hilda ...

Researchers awarded $22 million for medical research - Vimarsana News

Researchers awarded $22 million for medical research

Date Time Researchers awarded $22 million for medical research The University of Sydney has received funding for 14 projects from the Medical Research Future Fund (MRFF) to improve health outcomes for Australians. The Minister for Health and Aged Care, the Hon Greg Hunt, has announced $180 million in funding for 105 medical research projects, to improve health outcomes for Australians. Deputy Vice-Chancellor (Research), Professor Duncan Ivison welcomed the funding announcement which awarded $22.3 million to the University of Sydney for 14 projects. “The funding of these 14 projects...

Biologists unravel pathway for cancer cells to become immortal - Vimarsana News

Biologists unravel pathway for cancer cells to become immortal

Biologists unravel pathway for cancer cells to become immortal By: Richard C. Lewis  |  2021.03.03  |  11:07 am Cancer cells have been described as immortal because, unlike normal cells, they don’t age and die, but instead can continue to multiply without end. In most cases, cancer cells become immortal by invoking a genetic mutation that can trigger the production of an enzyme, known as telomerase, which prevents telomeres from shortening. Telomeres are important because they prevent DNA-containing chromosomes from damage or fusing with nearby chromosomes. The longer the telomere,...

Source: uiowa.edu